Risk factors for gastrointestinal bleeding associated with low-dose aspirin

This publication has 52 references indexed in Scilit:

• Low-Dose Aspirin Affects the Small Bowel Mucosa: Results of a Pilot Study With a Multidimensional Assessment
  Clinical Gastroenterology and Hepatology, 2009
• Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
  The Lancet, 2009
• ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
  Circulation, 2007
• Assessing the Burden of Disease in the United States Using Disability-Adjusted Life Years
  American Journal of Preventive Medicine, 2005
• Nonsteroidal antiinflammatory drugs and the small intestine
  Current Opinion in Gastroenterology, 2005
• Incidence of serious upper gastrointestinal bleeding/perforation in the general population:
  Journal of Clinical Epidemiology, 2002
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom
  BMJ, 1995
• Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events
  The Lancet, 1991
• Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
  New England Journal of Medicine, 1989